Eradicating malaria: Prospects and perils

Wednesday, October 27th
MaRS Discovery District Auditorium

MaRS - Building Canada's next generation of global technology companies. www.marsdd.com

New diagnostics and therapeutics for severe malaria
Dr. Kevin Kain; Professor of Medicine, University of Torontoand Director, S. Rotman Labs, McLaughlin-Rotman Centre forGlobal Health, University Health Network-Toronto General Hospital

2010 GAIRDNER GLOBAL HEALTH SYMPOSIUM: Artemisinins: Eradicating malaria: Prospects and perils

Opportunities and challenges
2010 Canada Gairdner Global Health Awardee
Dr. Nicholas White ; Professor of Tropical Medicine, Mahidol andOxford University, Bangkok

2010 GAIRDNER GLOBAL HEALTH SYMPOSIUM: Eradicating malaria: Prospects and perils

The Malaria Eradication Research Agenda (malERA)
Dr. Larry Slutsker, Malaria Branch Chief, Div of Parasitic Diseases andMalaria, CDC, Atlanta, GA

2010 GAIRDNER GLOBAL HEALTH SYMPOSIUM: Eradicating malaria: Prospects and perils

Malaria RTSS Vaccine
Dr. Ripley Ballou, Vice President and Head, Clinical Research andTranslational Science, Global Vaccine Development, GSK Belgium

2010 GAIRDNER GLOBAL HEALTH SYMPOSIUM: Eradicating malaria: Prospects and perils

Global economic strategy to reduce malaria deaths
Dr. Dean T. Jamison, Professor, Department of Global Health,University of Washington

2010 GAIRDNER GLOBAL HEALTH SYMPOSIUM: Eradicating malaria: Prospects and perils

The Gates Foundation perspective on malaria elimination
Dr. David Brandling- Bennett, Deputy Director, Malaria InfectiousDiseases, Global Health Program, Bill and Melinda GatesFoundation, Seattle WA

2010 GAIRDNER GLOBAL HEALTH SYMPOSIUM: Eradicating malaria: Prospects and perils

Malaria and Pregnancy
Dr. Feiko ter Kuile, Liverpool School of Tropical Medicine, UK

MaRS - Building Canada's next generation of global technology companies. marsdd.com